Roland Griffiths - Publications

Affiliations: 
School of Medicine Johns Hopkins University, Baltimore, MD 
Area:
Behavioral Pharmacology
Website:
http://www.bpru.org/bio/griffiths.html

188 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology (Oxford, England). 269881120967878. PMID 33427007 DOI: 10.1177/0269881120967878  0.96
2020 Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 33146667 DOI: 10.1001/jamapsychiatry.2020.3285  1
2020 Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, Griffiths RR, Barrett FS. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain. Scientific Reports. 10: 16392. PMID 33009457 DOI: 10.1038/s41598-020-73216-8  1
2020 Davis AK, Barrett FS, Griffiths RR. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science. 15: 39-45. PMID 32864325 DOI: 10.1016/j.jcbs.2019.11.004  0.96
2020 Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology. PMID 32500212 DOI: 10.1007/s00213-020-05533-9  1
2020 Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR. Survey of entity encounter experiences occasioned by inhaled -dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology (Oxford, England). 269881120916143. PMID 32345112 DOI: 10.1177/0269881120916143  1
2020 Sweeney MM, Weaver DC, Vincent KB, Arria AM, Griffiths RR. Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample. Journal of Caffeine and Adenosine Research. 10: 4-11. PMID 32181442 DOI: 10.1089/caff.2019.0020  0.84
2020 Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports. 10: 2214. PMID 32042038 DOI: 10.1038/s41598-020-59282-y  0.96
2020 Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence. 107849. PMID 32029298 DOI: 10.1016/j.drugalcdep.2020.107849  0.92
2019 Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Frontiers in Psychiatry. 10: 955. PMID 32038317 DOI: 10.3389/fpsyt.2019.00955  1
2019 Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881119845793. PMID 31084460 DOI: 10.1177/0269881119845793  1
2019 Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Plos One. 14: e0214377. PMID 31013281 DOI: 10.1371/journal.pone.0214377  1
2019 Davis AK, So S, Lancelotta R, Barsuglia JP, Griffiths RR. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. The American Journal of Drug and Alcohol Abuse. 1-9. PMID 30822141 DOI: 10.1080/00952990.2018.1545024  0.56
2018 Sweeney MM, Meredith SE, Juliano LM, Evatt DP, Griffiths RR. A randomized controlled trial of a manual-only treatment for reduction and cessation of problematic caffeine use. Drug and Alcohol Dependence. 195: 45-51. PMID 30580203 DOI: 10.1016/j.drugalcdep.2018.10.034  1
2018 Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR. Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study. Frontiers in Psychology. 9: 2459. PMID 30574112 DOI: 10.3389/fpsyg.2018.02459  0.56
2018 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics. Pharmacology & Therapeutics. PMID 30521880 DOI: 10.1016/j.pharmthera.2018.11.010  1
2018 Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology. PMID 30062577 DOI: 10.1007/s00213-018-4981-x  1
2018 Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology (Oxford, England). 269881118780612. PMID 29938565 DOI: 10.1177/0269881118780612  1
2018 Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology. PMID 29753748 DOI: 10.1016/j.neuropharm.2018.05.012  1
2017 Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology. PMID 29116367 DOI: 10.1007/s00213-017-4769-4  1
2017 Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England). 269881117731279. PMID 29020861 DOI: 10.1177/0269881117731279  1
2017 Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions. Frontiers in Psychology. 8: 1238. PMID 28790944 DOI: 10.3389/fpsyg.2017.01238  0.96
2017 Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 117: 155-160. PMID 28781400 DOI: 10.1016/j.paid.2017.06.004  1
2017 Johnson MW, Griffiths RR. Potential Therapeutic Effects of Psilocybin. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28585222 DOI: 10.1007/s13311-017-0542-y  1
2017 Barrett FS, Griffiths RR. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences. PMID 28401522 DOI: 10.1007/7854_2017_474  0.96
2017 Barrett FS, Griffiths RR. The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016. Human Psychopharmacology. 32. PMID 28120488 DOI: 10.1002/hup.2564  0.96
2017 Sweeney MM, Meredith SE, Evatt DP, Griffiths RR. Effects of caffeine on alcohol reinforcement: beverage choice, self-administration, and subjective ratings. Psychopharmacology. PMID 28108773 DOI: 10.1007/s00213-017-4528-6  0.84
2017 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881116684335. PMID 28095732 DOI: 10.1177/0269881116684335  1
2016 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England). 30: 1181-1197. PMID 27909165 DOI: 10.1177/0269881116675513  1
2016 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England). PMID 27856683 DOI: 10.1177/0269881116678781  1
2016 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England). PMID 27578767 DOI: 10.1177/0269881116662634  1
2016 Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse. 1-6. PMID 27441452 DOI: 10.3109/00952990.2016.1170135  1
2016 Meredith SE, Sweeney MM, Johnson PS, Johnson MW, Griffiths RR. Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults. Journal of Caffeine Research. 6: 10-19. PMID 26989563 DOI: 10.1089/jcr.2015.0024  1
2016 Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans. Journal of Psychopharmacology (Oxford, England). PMID 26880225 DOI: 10.1177/0269881116629125  0.6
2016 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, et al. Naltrexone but not ketanserin antagonizes the subjective, cardiovascular and neuroendocrine effects of salvinorin-A in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26874330 DOI: 10.1093/ijnp/pyw016  1
2015 Evatt DP, Juliano LM, Griffiths RR. A Brief Manualized Treatment for Problematic Caffeine Use: A Randomized Control Trial. Journal of Consulting and Clinical Psychology. PMID 26501499 DOI: 10.1037/ccp0000064  0.56
2015 Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England). 29: 1182-90. PMID 26442957 DOI: 10.1177/0269881115609019  1
2015 Hendricks PS, Johnson MW, Griffiths RR. Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacology (Oxford, England). 29: 1041-3. PMID 26395582 DOI: 10.1177/0269881115598338  1
2015 Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacology. PMID 26345343 DOI: 10.1007/s00213-015-4053-4  1
2015 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J. Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26047623 DOI: 10.1093/ijnp/pyv065  1
2015 Dale S, Levi C, Ward J, Grimshaw JM, Jammali-Blasi A, D'Este C, Griffiths R, Quinn C, Evans M, Cadilhac D, Cheung NW, Middleton S. Barriers and enablers to implementing clinical treatment protocols for fever, hyperglycaemia, and swallowing dysfunction in the Quality in Acute Stroke Care (QASC) Project--a mixed methods study. Worldviews On Evidence-Based Nursing / Sigma Theta Tau International, Honor Society of Nursing. 12: 41-50. PMID 25604606 DOI: 10.1111/wvn.12078  0.68
2015 Duffield C, Graham E, Donoghue J, Griffiths R, Bichel-Findlay J, Dimitrelis S. Why older nurses leave the workforce and the implications of them staying. Journal of Clinical Nursing. 24: 824-31. PMID 25524135 DOI: 10.1111/jocn.12747  0.36
2015 Reissig CJ, Harrison JA, Carter LP, Griffiths RR. Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potential. Psychopharmacology. 232: 871-83. PMID 25199955 DOI: 10.1007/s00213-014-3721-0  1
2014 Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews. 7: 157-64. PMID 25563443 DOI: 10.2174/1874473708666150107121331  1
2014 Graham E, Donoghue J, Duffield C, Griffiths R, Bichel-Findlay J, Dimitrelis S. Why do older RNs keep working? The Journal of Nursing Administration. 44: 591-7. PMID 25340924 DOI: 10.1097/NNA.0000000000000131  0.36
2014 Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England). 28: 983-92. PMID 25213996 DOI: 10.1177/0269881114548296  1
2014 Jenkins RK, Tognelli MF, Bowles P, Cox N, Brown JL, Chan L, Andreone F, Andriamazava A, Andriantsimanarilafy RR, Anjeriniaina M, Bora P, Brady LD, Hantalalaina EF, Glaw F, Griffiths RA, et al. Extinction risks and the conservation of Madagascar's reptiles. Plos One. 9: e100173. PMID 25111137 DOI: 10.1371/journal.pone.0100173  0.6
2014 Mansah M, Griffiths R, Fernandez R, Chang E, Thuy Tran D. Older folks in hospitals: the contributing factors and recommendations for incident prevention. Journal of Patient Safety. 10: 146-53. PMID 24618649 DOI: 10.1097/PTS.0b013e31829954fd  0.68
2014 Drury P, Levi C, D'Este C, McElduff P, McInnes E, Hardy J, Dale S, Cheung NW, Grimshaw JM, Quinn C, Ward J, Evans M, Cadilhac D, Griffiths R, Middleton S. Quality in Acute Stroke Care (QASC): process evaluation of an intervention to improve the management of fever, hyperglycemia, and swallowing dysfunction following acute stroke. International Journal of Stroke : Official Journal of the International Stroke Society. 9: 766-76. PMID 24289456 DOI: 10.1111/ijs.12202  0.68
2014 Drury P, Levi C, McInnes E, Hardy J, Ward J, Grimshaw JM, D' Este C, Dale S, McElduff P, Cheung NW, Quinn C, Griffiths R, Evans M, Cadilhac D, Middleton S. Management of fever, hyperglycemia, and swallowing dysfunction following hospital admission for acute stroke in New South Wales, Australia. International Journal of Stroke : Official Journal of the International Stroke Society. 9: 23-31. PMID 24206841 DOI: 10.1111/ijs.12194  0.68
2013 Meredith SE, Juliano LM, Hughes JR, Griffiths RR. Caffeine Use Disorder: A Comprehensive Review and Research Agenda. Journal of Caffeine Research. 3: 114-130. PMID 24761279 DOI: 10.1089/jcr.2013.0016  1
2013 Budney AJ, Brown PC, Griffiths RR, Hughes JR, Juliano LM. Caffeine Withdrawal and Dependence: A Convenience Survey Among Addiction Professionals. Journal of Caffeine Research. 3: 67-71. PMID 24761276 DOI: 10.1089/jcr.2013.0005  1
2013 Caspers MJ, Williams TD, Lovell KM, Lozama A, Butelman ER, Kreek MJ, Johnson M, Griffiths R, Maclean K, Prisinzano TE. LC-MS/MS quantification of salvinorin A from biological fluids. Analytical Methods : Advancing Methods and Applications. 5. PMID 24416081 DOI: 10.1039/C3AY40810H  1
2013 Johnson MW, Griffiths RR. Comparative abuse liability of GHB and ethanol in humans. Experimental and Clinical Psychopharmacology. 21: 112-23. PMID 23421353 DOI: 10.1037/a0031692  1
2013 MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology. 226: 381-92. PMID 23135605 DOI: 10.1007/s00213-012-2912-9  1
2013 Carter LP, Kleykamp BA, Griffiths RR, Mintzer MZ. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers. Psychopharmacology. 226: 53-63. PMID 23096769 DOI: 10.1007/s00213-012-2883-x  1
2013 Connell T, Fernandez RS, Tran D, Griffiths R, Harlum J, Agar M. Quality of life of community-based palliative care clients and their caregivers. Palliative & Supportive Care. 11: 323-30. PMID 23083944 DOI: 10.1017/S1478951512000260  0.36
2013 Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug and Alcohol Dependence. 128: 206-13. PMID 22989498 DOI: 10.1016/j.drugalcdep.2012.08.025  1
2012 Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal For the Scientific Study of Religion. 51: 721-737. PMID 23316089 DOI: 10.1111/j.1468-5906.2012.01685.x  1
2012 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 223: 1-15. PMID 22526529 DOI: 10.1007/s00213-012-2680-6  1
2012 Juliano LM, Evatt DP, Richards BD, Griffiths RR. Characterization of individuals seeking treatment for caffeine dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 26: 948-54. PMID 22369218 DOI: 10.1037/a0027246  1
2012 Johnson MW, Sewell RA, Griffiths RR. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug and Alcohol Dependence. 123: 132-40. PMID 22129843 DOI: 10.1016/j.drugalcdep.2011.10.029  1
2012 Kleykamp BA, Griffiths RR, McCann UD, Smith MT, Mintzer MZ. Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use. Experimental and Clinical Psychopharmacology. 20: 28-39. PMID 21928913 DOI: 10.1037/a0025237  1
2011 Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, Drury P, Griffiths R, Cheung NW, Quinn C, Evans M, Cadilhac D, Levi C. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 378: 1699-706. PMID 21996470 DOI: 10.1016/S0140-6736(11)61485-2  0.68
2011 MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology (Oxford, England). 25: 1453-61. PMID 21956378 DOI: 10.1177/0269881111420188  1
2011 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 218: 649-65. PMID 21674151 DOI: 10.1007/s00213-011-2358-5  1
2011 Sigmon SC, Griffiths RR. Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine. Drug and Alcohol Dependence. 118: 341-8. PMID 21600707 DOI: 10.1016/j.drugalcdep.2011.04.018  1
2011 Shanley C, Whitmore E, Conforti D, Masso J, Jayasinghe S, Griffiths R. Decisions about transferring nursing home residents to hospital: highlighting the roles of advance care planning and support from local hospital and community health services. Journal of Clinical Nursing. 20: 2897-906. PMID 21539626 DOI: 10.1111/j.1365-2702.2010.03635.x  0.68
2011 Connell T, Griffiths R, Fernandez RS, Tran D, Agar M, Harlum J. Quality-of-life trajectory of clients and carers referred to a community palliative care service. International Journal of Palliative Nursing. 17: 80-5. PMID 21378692 DOI: 10.12968/ijpn.2011.17.2.80  0.36
2011 Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence. 115: 150-5. PMID 21131142 DOI: 10.1016/j.drugalcdep.2010.11.005  1
2011 Goodwin AK, Kaminski BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons. Drug and Alcohol Dependence. 114: 217-24. PMID 21112162 DOI: 10.1016/j.drugalcdep.2010.10.006  1
2011 Arria AM, Caldeira KM, Kasperski SJ, Vincent KB, Griffiths RR, O'Grady KE. Energy drink consumption and increased risk for alcohol dependence. Alcoholism, Clinical and Experimental Research. 35: 365-75. PMID 21073486 DOI: 10.1111/j.1530-0277.2010.01352.x  1
2011 Middleton S, Levi C, Ward J, Grimshaw J, Griffiths R, D'Este C, Dale S, Quinn C, Evans M, Cadilhac D, McElduff P. Death, dependency and health status 90 days following hospital admission for acute stroke in NSW. Internal Medicine Journal. 41: 736-43. PMID 20681960 DOI: 10.1111/j.1445-5994.2010.02330.x  0.68
2011 Fernandez RS, Davidson P, Griffiths R, Salamonson Y. Improving cardiac rehabilitation services--challenges for cardiac rehabilitation coordinators. European Journal of Cardiovascular Nursing : Journal of the Working Group On Cardiovascular Nursing of the European Society of Cardiology. 10: 37-43. PMID 20594916 DOI: 10.1016/j.ejcnurse.2010.03.007  0.36
2010 Jefferies D, Johnson M, Griffiths R, Arthurs K, Beard D, Chen T, Edgetton-Winn M, Hecimovic T, Hughes M, Linten K, Maddox J, McCaul D, Robson K, Scott S, Zarkos T. Engaging clinicians in evidence based policy development: the case of nursing documentation. Contemporary Nurse. 35: 254-64. PMID 20950205 DOI: 10.5172/conu.2010.35.2.254  0.68
2010 Connell T, Fernandez RS, Griffiths R, Tran D, Agar M, Harlum J, Langdon R. Perceptions of the impact of health-care services provided to palliative care clients and their carers. International Journal of Palliative Nursing. 16: 274-84. PMID 20925290 DOI: 10.12968/ijpn.2010.16.6.48829  0.4
2010 Arria AM, Caldeira KM, Kasperski SJ, O'Grady KE, Vincent KB, Griffiths RR, Wish ED. Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students. Journal of Addiction Medicine. 4: 74-80. PMID 20729975 DOI: 10.1097/ADM.0b013e3181aa8dd4  1
2010 Johnson MW, Strain EC, Griffiths RR. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Experimental and Clinical Psychopharmacology. 18: 305-15. PMID 20695686 DOI: 10.1037/a0020509  1
2010 Fernandez RS, Davidson P, Griffiths R, Salamonson Y. Overcoming barriers to guideline implementation: the case of cardiac rehabilitation. Quality & Safety in Health Care. 19: e15. PMID 20584704 DOI: 10.1136/qshc.2008.029587  0.36
2010 Jefferies D, Johnson M, Griffiths R. A meta-study of the essentials of quality nursing documentation. International Journal of Nursing Practice. 16: 112-24. PMID 20487056 DOI: 10.1111/j.1440-172X.2009.01815.x  0.88
2010 Fernandez RS, Chau JP, Thompson DR, Griffiths R, Lo HS. Accuracy of biochemical markers for predicting nasogastric tube placement in adults--a systematic review of diagnostic studies. International Journal of Nursing Studies. 47: 1037-46. PMID 20399427 DOI: 10.1016/j.ijnurstu.2010.03.015  0.36
2010 Mintzer MZ, Kleykamp BA, Griffiths RR. Dose effects of triazolam and scopolamine on metamemory. Experimental and Clinical Psychopharmacology. 18: 17-31. PMID 20158291 DOI: 10.1037/a0018061  1
2010 Kleykamp BA, Griffiths RR, Mintzer MZ. Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Experimental and Clinical Psychopharmacology. 18: 1-16. PMID 20158290 DOI: 10.1037/a0018407  1
2010 Oupra R, Griffiths R, Pryor J, Mott S. Effectiveness of Supportive Educative Learning programme on the level of strain experienced by caregivers of stroke patients in Thailand. Health & Social Care in the Community. 18: 10-20. PMID 19519873 DOI: 10.1111/j.1365-2524.2009.00865.x  0.68
2009 Fernandez RS, Davidson P, Griffiths R, Juergens C, Salamonson Y. Development of a health-related lifestyle self-management intervention for patients with coronary heart disease. Heart & Lung : the Journal of Critical Care. 38: 491-8. PMID 19944873 DOI: 10.1016/j.hrtlng.2009.01.008  0.36
2009 Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Does implementation of clinical practice guidelines change nurses' screening for alcohol and other substance use? Contemporary Nurse. 33: 13-9. PMID 19715491 DOI: 10.5555/conu.33.1.13  0.36
2009 Carter LP, Griffiths RR, Mintzer MZ. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacology. 206: 141-54. PMID 19543883 DOI: 10.1007/s00213-009-1589-1  1
2009 Griffiths R, Horsfall J, Moore M, Lane D, Kroon V, Langdon R. Building social capital with women in a socially disadvantaged community. International Journal of Nursing Practice. 15: 172-84. PMID 19531075 DOI: 10.1111/j.1440-172X.2009.01742.x  0.4
2009 Carter LP, Pardi D, Gorsline J, Griffiths RR. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug and Alcohol Dependence. 104: 1-10. PMID 19493637 DOI: 10.1016/j.drugalcdep.2009.04.012  1
2009 Carter LP, Griffiths RR. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence. 105: S14-25. PMID 19443137 DOI: 10.1016/j.drugalcdep.2009.04.003  1
2009 Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Changes in general nurses' knowledge of alcohol and substance use and misuse after education. Perspectives in Psychiatric Care. 45: 128-39. PMID 19366423 DOI: 10.1111/j.1744-6163.2009.00213.x  0.36
2009 Middleton S, Levi C, Ward J, Grimshaw J, Griffiths R, D'Este C, Dale S, Cheung NW, Quinn C, Evans M, Cadilhac D. Fever, hyperglycaemia and swallowing dysfunction management in acute stroke: a cluster randomised controlled trial of knowledge transfer. Implementation Science : Is. 4: 16. PMID 19291323 DOI: 10.1186/1748-5908-4-16  0.36
2009 Sigmon SC, Herning RI, Better W, Cadet JL, Griffiths RR. Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology. 204: 573-85. PMID 19241060 DOI: 10.1007/s00213-009-1489-4  1
2009 Fernandez RS, Davidson P, Griffiths R, Juergens C, Stafford B, Salamonson Y. A pilot randomised controlled trial comparing a health-related lifestyle self-management intervention with standard cardiac rehabilitation following an acute cardiac event: Implications for a larger clinical trial. Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses. 22: 17-27. PMID 19081265 DOI: 10.1016/j.aucc.2008.10.003  0.36
2009 Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks--a growing problem. Drug and Alcohol Dependence. 99: 1-10. PMID 18809264 DOI: 10.1016/j.drugalcdep.2008.08.001  1
2008 Fernandez RS, Salamonson Y, Griffiths R, Juergens C, Davidson P. Awareness of risk factors for coronary heart disease following interventional cardiology procedures: a key concern for nursing practice. International Journal of Nursing Practice. 14: 435-42. PMID 19126071 DOI: 10.1111/j.1440-172X.2008.00717.x  0.36
2008 Fernandez RS, Davidson P, Griffiths R. Cardiac rehabilitation coordinators' perceptions of patient-related barriers to implementing cardiac evidence-based guidelines. The Journal of Cardiovascular Nursing. 23: 449-57. PMID 18728518 DOI: 10.1097/01.JCN.0000317450.64778.a0  0.36
2008 Griffiths R, Richards W, Johnson M, McCann U, Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England). 22: 621-32. PMID 18593735 DOI: 10.1177/0269881108094300  0.88
2008 Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology (Oxford, England). 22: 603-20. PMID 18593734 DOI: 10.1177/0269881108093587  0.88
2008 Fernandez RS, Salamonson Y, Griffiths R, Juergens C, Davidson P. Sociodemographic predictors and reasons for participation in an outpatient cardiac rehabilitation programme following percutaneous coronary intervention. International Journal of Nursing Practice. 14: 237-42. PMID 18460065 DOI: 10.1111/j.1440-172X.2008.00685.x  0.36
2008 Fernandez RS, Griffiths R, Aguilar V, Tran D, Chester R. Administration of medications by enrolled nurses: perceptions of metropolitan and non-metropolitan registered nurses and nursing unit managers. Contemporary Nurse. 27: 237-45. PMID 18457523 DOI: 10.5555/conu.2008.27.2.237  0.36
2008 Dennis SM, Zwar N, Griffiths R, Roland M, Hasan I, Powell Davies G, Harris M. Chronic disease management in primary care: from evidence to policy. The Medical Journal of Australia. 188: S53-6. PMID 18429737  0.36
2008 Fernandez RS, Salamonson Y, Juergens C, Griffiths R, Davidson P. Development and preliminary testing of the Cardiac Rehabilitation Enrolment Obstacles (CREO) scale: implications for service development. European Journal of Cardiovascular Nursing : Journal of the Working Group On Cardiovascular Nursing of the European Society of Cardiology. 7: 96-102. PMID 17950036 DOI: 10.1016/j.ejcnurse.2007.09.002  0.36
2007 Fernandez RS, Griffiths R, Ussia C. Water for wound cleansing. International Journal of Evidence-Based Healthcare. 5: 305-23. PMID 21631794 DOI: 10.1111/j.1479-6988.2007.00068.x  0.36
2007 Fernandez RS, Salamonson Y, Juergens C, Griffiths R, Davidson P. Validation of the revised cardiac rehabilitation preference form in patients with post-percutaneous coronary intervention. Journal of Cardiopulmonary Rehabilitation and Prevention. 27: 390-4. PMID 18197074 DOI: 10.1097/01.HCR.0000300267.92516.23  0.36
2007 Fernandez RS, Griffiths R. Portable MP3 players: innovative devices for recording qualitative interviews. Nurse Researcher. 15: 7-15. PMID 17992811 DOI: 10.7748/nr2007.10.15.1.7.c6050  0.36
2007 Griffiths RD, Stone A, Tran DT, Fernandez RS, Ford K. Drink a little; take a few drugs: do nurses have knowledge to identify and manage in-patients at risk of drugs and alcohol? Drug and Alcohol Review. 26: 545-52. PMID 17701518 DOI: 10.1080/09595230701499167  0.36
2007 Mintzer MZ, Griffiths RR. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. Cognitive, Affective & Behavioral Neuroscience. 7: 120-9. PMID 17672383 DOI: 10.3758/CABN.7.2.120  1
2007 Fernandez RS, Davidson P, Salamonson Y, Griffiths R, Juergens C. The health-related quality of life trajectory in patients after percutaneous coronary intervention. Journal of Cardiopulmonary Rehabilitation and Prevention. 27: 223-6. PMID 17667018 DOI: 10.1097/01.HCR.0000281767.59781.a1  0.36
2007 Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. The Journal of Pharmacology and Experimental Therapeutics. 322: 749-59. PMID 17502431 DOI: 10.1124/jpet.107.119693  1
2007 Mintzer MZ, Griffiths RR. A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal. Psychopharmacology. 192: 425-40. PMID 17342474 DOI: 10.1007/s00213-007-0726-y  1
2007 Griffiths R, Horsfall J, Moore M, Lane D, Kroon V, Langdon R. Assessment of health, well-being and social connections: a survey of women living in Western Sydney. International Journal of Nursing Practice. 13: 3-13. PMID 17244240 DOI: 10.1111/j.1440-172X.2006.00606.x  0.4
2007 Weerts EM, Froestl W, Kaminski BJ, Griffiths RR. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug and Alcohol Dependence. 89: 206-13. PMID 17234367 DOI: 10.1016/j.drugalcdep.2006.12.023  1
2006 Lofwall MR, Griffiths RR, Mintzer MZ. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults. Experimental and Clinical Psychopharmacology. 14: 439-49. PMID 17115871 DOI: 10.1037/1064-1297.14.4.439  1
2006 Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM, Weerts EM. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology. 189: 71-82. PMID 17047936 DOI: 10.1007/s00213-006-0534-9  1
2006 Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Archives of General Psychiatry. 63: 1149-57. PMID 17015817 DOI: 10.1001/archpsyc.63.10.1149  1
2006 Carter LP, Richards BD, Mintzer MZ, Griffiths RR. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2537-51. PMID 16880774 DOI: 10.1038/sj.npp.1301146  1
2006 Mintzer MZ, Kuwabara H, Alexander M, Brasic JR, Ye W, Ernst M, Griffiths RR, Wong DF. Dose effects of triazolam on brain activity during episodic memory encoding: a PET study. Psychopharmacology. 188: 445-61. PMID 16847681 DOI: 10.1007/s00213-006-0446-8  1
2006 Grudzinskas C, Balster RL, Gorodetzky CW, Griffiths RR, Henningfield JE, Johanson CE, Mansbach RS, McCormick CG, Schnoll SH, Strain EC, Wright C. Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report. Drug and Alcohol Dependence. 83: S77-82. PMID 16580154 DOI: 10.1016/j.drugalcdep.2006.02.008  1
2005 Mintzer MZ, Griffiths RR. Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine. Experimental and Clinical Psychopharmacology. 13: 336-47. PMID 16366764 DOI: 10.1037/1064-1297.13.4.336  1
2005 Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. The Journal of Clinical Psychiatry. 66: 31-41. PMID 16336040  1
2005 Svikis DS, Berger N, Haug NA, Griffiths RR. Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. The American Journal of Psychiatry. 162: 2344-51. PMID 16330600 DOI: 10.1176/appi.ajp.162.12.2344  1
2005 Mintzer MZ, Griffiths RR. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers. Behavioural Pharmacology. 16: 579-84. PMID 16170235 DOI: 10.1097/01.fbp.0000172736.11994.3c  1
2005 Weerts EM, Ator NA, Kaminski BJ, Griffiths RR. Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons. European Journal of Pharmacology. 519: 103-13. PMID 16129429 DOI: 10.1016/j.ejphar.2005.06.038  1
2005 Weerts EM, Froestl W, Griffiths RR. Effects of GABAergic modulators on food and cocaine self-administration in baboons. Drug and Alcohol Dependence. 80: 369-76. PMID 16005580 DOI: 10.1016/j.drugalcdep.2005.05.006  1
2005 Ator NA, Griffiths RR, Weerts EM. Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons. Drug and Alcohol Dependence. 78: 113-23. PMID 15845314 DOI: 10.1016/j.drugalcdep.2004.09.007  1
2005 Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nursing (Boston, Mass.). 22: 36-44. PMID 15670323 DOI: 10.1111/j.0737-1209.2005.22106.x  0.88
2005 Weerts EM, Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology. 179: 678-87. PMID 15645222 DOI: 10.1007/s00213-004-2079-0  1
2005 Mintzer MZ, Griffiths RR. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure. Psychopharmacology. 178: 259-67. PMID 15452683 DOI: 10.1007/s00213-004-2009-1  1
2004 Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features Psychopharmacology. 176: 1-29. PMID 15448977 DOI: 10.1007/s00213-004-2000-x  1
2004 Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. International Journal of Nursing Practice. 10: 166-76. PMID 15265227 DOI: 10.1111/j.1440-172X.2004.00476.x  0.88
2004 Sobel BFX, Sigmon SC, Griffiths RR. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers Neuropsychopharmacology. 29: 991-1003. PMID 15010695 DOI: 10.1038/sj.npp.1300415  1
2003 Kaminski BJ, Sannerud CA, Weerts EM, Lamb RJ, Griffiths RR. Physical dependence in baboons chronically treated with low and high doses of diazepam. Behavioural Pharmacology. 14: 331-42. PMID 12838039 DOI: 10.1097/01.fbp.0000082131.08343.0e  1
2003 Mintzer MZ, Griffiths RR, Hirshman E. A paradoxical dissociation in the effects of midazolam on recollection and automatic processes in the process dissociation procedure. The American Journal of Psychology. 116: 213-37. PMID 12762176  1
2003 Ator NA, Griffiths RR. Principles of drug abuse liability assessment in laboratory animals. Drug and Alcohol Dependence. 70: S55-72. PMID 12759197  0.64
2003 Griffiths RR, Bigelow GE, Ator NA. Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence. 70: S41-54. PMID 12759196 DOI: 10.1016/S0376-8716(03)00098-X  1
2003 Mintzer MZ, Griffiths RR. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal. Journal of Psychopharmacology (Oxford, England). 17: 17-29. PMID 12680736 DOI: 10.1177/0269881103017001689  1
2003 Weerts EM, Griffiths RR. The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons. Psychopharmacology. 168: 155-63. PMID 12669180 DOI: 10.1007/s00213-003-1410-5  1
2003 Mintzer MZ, Griffiths RR. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes. Experimental and Clinical Psychopharmacology. 11: 56-72. PMID 12622344 DOI: 10.1037//1064-1297.11.1.56  1
2002 Mintzer MZ, Griffiths RR. Alcohol and triazolam: differential effects on memory, psychomotor performance and subjective ratings of effects. Behavioural Pharmacology. 13: 653-8. PMID 12478216 DOI: 10.1097/01.fbp.0000046507.84018.61  1
2001 Johnson M, Griffiths R. Developing evidence-based clinicians. International Journal of Nursing Practice. 7: 109-18. PMID 11811313  0.88
2001 Mintzer MZ, Griffiths RR. Alcohol and false recognition: a dose-effect study. Psychopharmacology. 159: 51-7. PMID 11797069 DOI: 10.1007/s002130100893  1
2001 Mintzer MZ, Griffiths RR, Contoreggi C, Kimes AS, London ED, Ernst M. Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 744-56. PMID 11682258 DOI: 10.1016/S0893-133X(01)00280-9  1
2001 Mintzer MZ, Allen RP, Griffiths RR. Investigation of preference for nightly triazolam versus placebo in moderate social alcohol drinkers. Journal of Psychopharmacology (Oxford, England). 15: 3-8. PMID 11277606  1
2001 Mintzer MZ, Griffiths RR. Acute dose-effects of scopolamine on false recognition. Psychopharmacology. 153: 425-33. PMID 11243489 DOI: 10.1007/s002130000592  1
2000 Mintzer MZ, Griffiths RR. Acute effects of triazolam on false recognition. Memory & Cognition. 28: 1357-65. PMID 11219963  1
2000 Ator NA, Weerts EM, Kaminski BJ, Kautz MA, Griffiths RR. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug and Alcohol Dependence. 61: 69-84. PMID 11064185 DOI: 10.1016/S0376-8716(00)00122-8  1
1999 Weerts EM, Griffiths RR. Evaluation of limited and unlimited food intake during withdrawal in triazolam-dependent baboons. Behavioural Pharmacology. 10: 415-21. PMID 10780809  1
1999 Weerts EM, Ator NA, Griffiths RR. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug and Alcohol Dependence. 57: 51-60. PMID 10617313 DOI: 10.1016/S0376-8716(99)00044-7  1
1999 Mintzer MZ, Stoller KB, Griffiths RR. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 147: 200-9. PMID 10591888  1
1999 Mintzer MZ, Griffiths RR. Triazolam and zolpidem: effects on human memory and attentional processes. Psychopharmacology. 144: 8-19. PMID 10379619 DOI: 10.1007/s002130050971  1
1999 Mintzer MZ, Griffiths RR. Selective effects of zolpidem on human memory functions. Journal of Psychopharmacology (Oxford, England). 13: 18-31. PMID 10221356  1
1999 Weerts EM, Griffiths RR. Evaluation of the intravenous reinforcing effects of clonidine in baboons. Drug and Alcohol Dependence. 53: 207-14. PMID 10080046 DOI: 10.1016/S0376-8716(98)00130-6  1
1998 Mintzer MZ, Griffiths RR. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability. Drug and Alcohol Dependence. 53: 49-66. PMID 10933340 DOI: 10.1016/S0376-8716(98)00110-0  1
1998 Mintzer MZ, Frey JM, Griffiths RR. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure. Behavioural Pharmacology. 9: 545-59. PMID 9862080  1
1998 Weerts EM, Griffiths RR. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behavioural Pharmacology. 9: 285-97. PMID 9832941  1
1998 Frey JM, Mintzer MZ, Rush CR, Griffiths RR. Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure. Psychopharmacology. 138: 16-26. PMID 9694522 DOI: 10.1007/s002130050640  1
1998 Weerts EM, Ator NA, Grech DM, Griffiths RR. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. The Journal of Pharmacology and Experimental Therapeutics. 285: 41-53. PMID 9535993  1
1998 Weerts EM, Kaminski BJ, Griffiths RR. Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Psychopharmacology. 135: 70-81. PMID 9489936 DOI: 10.1007/s002130050487  1
1997 Mintzer MZ, Frey JM, Yingling JE, Griffiths RR. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behavioural Pharmacology. 8: 561-74. PMID 9832970  1
1997 Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse. Psychopharmacology. 134: 1-37. PMID 9399364 DOI: 10.1007/s002130050422  1
1997 Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers. Experimental and Clinical Psychopharmacology. 5: 203-15. PMID 9260068 DOI: 10.1037/1064-1297.5.3.203  1
1996 Mumford GK, Benowitz NL, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR. Absorption rate of methylxanthines following capsules, cola and chocolate. European Journal of Clinical Pharmacology. 51: 319-25. PMID 9010706 DOI: 10.1007/s002280050205  1
1995 Rush CR, Critchfield TS, Troisi JR, Griffiths RR. Discriminative stimulus effects of diazepam and buspirone in normal volunteers. Journal of the Experimental Analysis of Behavior. 63: 277-94. PMID 7751833 DOI: 10.1901/jeab.1995.63-277  1
1994 Evans SM, Critchfield TS, Griffiths RR. Caffeine reinforcement demonstrated in a majority of moderate caffeine users. Behavioural Pharmacology. 5: 231-238. PMID 11224272  1
1994 Silverman K, Mumford GK, Griffiths RR. A procedure for studying the within-session onset of human drug discrimination. Journal of the Experimental Analysis of Behavior. 61: 181-9. PMID 8169567 DOI: 10.1901/jeab.1994.61-181  1
1994 Strain EC, Mumford GK, Silverman K, Griffiths RR. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations. Jama. 272: 1043-8. PMID 8089887  1
1994 Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR. Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology. 115: 1-8. PMID 7862879 DOI: 10.1007/BF02244744  1
1994 Silverman K, Mumford GK, Griffiths RR. Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology. 114: 424-32. PMID 7855200 DOI: 10.1007/BF02249332  1
1994 Silverman K, Kirby KC, Griffiths RR. Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology. 114: 243-7. PMID 7838915 DOI: 10.1007/BF02244844  1
1993 Troisi 2nd JR, Critchfield TS, Griffiths RR. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice. Behavioural Pharmacology. 4: 217-230. PMID 11224189  1
1993 Griffiths RR, Troisi JR, Silverman K, Mumford GK. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behavioural Pharmacology. 4: 3-13. PMID 11224166  1
1993 Lamb RJ, Griffiths RR. Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons. The Journal of Pharmacology and Experimental Therapeutics. 265: 47-52. PMID 8474029  1
1992 Silverman K, Griffiths RR. Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. Journal of the Experimental Analysis of Behavior. 57: 91-107. PMID 1548451 DOI: 10.1901/jeab.1992.57-91  1
1992 Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. The New England Journal of Medicine. 327: 1109-14. PMID 1528206 DOI: 10.1056/NEJM199210153271601  1
1991 Evans SM, Critchfield TS, Griffiths RR. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore. British Journal of Addiction. 86: 1625-32. PMID 1686197  1
1991 Griffiths RR, Lamb RJ, Sannerud CA, Ator NA, Brady JV. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology. 103: 154-61. PMID 1674158 DOI: 10.1007/BF02244196  1
1990 Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology. 102: 183-90. PMID 2125734 DOI: 10.1007/BF02245920  1
1990 Silverman K, Griffiths RR. Low-dose caffeine discrimination in normal humans. Nida Research Monograph. 105: 444-5. PMID 1876068  1
1990 Critchfield TS, Griffiths R. Behavioral and subjective effects of buspirone and lorazepam in sedative abusers: supra-therapeutic doses. Nida Research Monograph. 105: 318. PMID 1876027  1
1987 Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacology Series. 3: 83-7. PMID 3823094  1
1987 Lamb RJ, Sannerud CA, Griffiths RR. An examination of the intravenous self-administration of phenylpropanolamine using a cocaine substitution procedure in the baboon. Pharmacology, Biochemistry, and Behavior. 28: 389-92. PMID 3685074  1
1987 Lamb RJ, Griffiths RR. Effects of Ro 15-1788 and CGS 8216 in diazepam-dependent baboons. European Journal of Pharmacology. 143: 205-12. PMID 3121366  1
1987 Lamb RJ, Griffiths RR. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology. 91: 268-72. PMID 2882537  1
1985 Lamb RJ, Griffiths RR. Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons. European Journal of Pharmacology. 110: 257-61. PMID 2859217  1
1985 Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neuroscience and Biobehavioral Reviews. 9: 133-51. PMID 2858078 DOI: 10.1016/0149-7634(85)90039-9  1
1984 Lamb RJ, Griffiths RR. Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896. Drug and Alcohol Dependence. 14: 11-7. PMID 6435982  1
1984 Griffiths RR, Ator NA, Lukas SE, Lamb RJ, Brady JV. Benzodiazepines: drug discrimination and physiological dependence. Nida Research Monograph. 49: 163-4. PMID 6148692  1
Show low-probability matches.